First Time Loading...

Redhill Biopharma Ltd
NASDAQ:RDHL

Watchlist Manager
Redhill Biopharma Ltd Logo
Redhill Biopharma Ltd
NASDAQ:RDHL
Watchlist
Price: 0.451 USD 4.57%
Updated: May 2, 2024

Redhill Biopharma Ltd
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Redhill Biopharma Ltd
Revenue Peer Comparison

Comparables:
T
TEVA
TARO
I
INCR
MDWD
R
REKA

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Redhill Biopharma Ltd
NASDAQ:RDHL
Revenue
$6.5m
CAGR 3-Years
-53%
CAGR 5-Years
-5%
CAGR 10-Years
N/A
T
Teva Pharmaceutical Industries Ltd
TASE:TEVA
Revenue
$15.8B
CAGR 3-Years
-2%
CAGR 5-Years
-3%
CAGR 10-Years
-2%
Taro Pharmaceutical Industries Ltd
NYSE:TARO
Revenue
$610.8m
CAGR 3-Years
2%
CAGR 5-Years
-2%
CAGR 10-Years
-2%
I
InterCure Ltd
TASE:INCR
Revenue
₪414.8m
CAGR 3-Years
164%
CAGR 5-Years
N/A
CAGR 10-Years
48%
Mediwound Ltd
NASDAQ:MDWD
Revenue
$18.7m
CAGR 3-Years
-5%
CAGR 5-Years
41%
CAGR 10-Years
N/A
R
Rekah Pharmaceutical Industry Ltd
TASE:REKA
Revenue
₪315.3m
CAGR 3-Years
10%
CAGR 5-Years
9%
CAGR 10-Years
1%

See Also

What is Redhill Biopharma Ltd's Revenue?
Revenue
6.5m USD

Based on the financial report for Dec 31, 2023, Redhill Biopharma Ltd's Revenue amounts to 6.5m USD.

What is Redhill Biopharma Ltd's Revenue growth rate?
Revenue CAGR 5Y
-5%

Over the last year, the Revenue growth was -89%. The average annual Revenue growth rates for Redhill Biopharma Ltd have been -53% over the past three years , -5% over the past five years .